Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yvette M. Vigna"'
Publikováno v:
Obstetrics and Gynecology International, Vol 2011 (2011)
We report menstrual and mid-cycle patterns of self-reported “fluid retention” in 765 menstrual cycles in 62 healthy women. Self-reported “fluid retention,” commonly described as bloating, is one element of the clinical assessment and diagnosi
Externí odkaz:
https://doaj.org/article/afb31d85a03946f7b63380b828941c84
Publikováno v:
Geburtshilfe und Frauenheilkunde. 76(8)
Introduction: Although a fragility fracture family history (FFFH+) has repeatedly been shown to be associated with lower bone mineral density (BMD), its relationship to human BMD change is unclear. Animal research, however, documented that different
Autor:
Christine L. Hitchcock, Lucy A. Williams, Yvette M. Vigna, Jason D. Nielsen, Charmaine B. Dean, Jerilynn C. Prior
Publikováno v:
Clinical Science. 112:517-525
Oestrogen therapy is the gold standard treatment for hot flushes/night sweats, but it and oestrogen/progestin are not suitable for all women. MPA (medroxyprogesterone acetate) reduces hot flushes, but its effectiveness compared with oestrogen is unkn
Publikováno v:
Journal of Bone and Mineral Research. 16:940-947
This 2-year prospective study examined associations among bone mineral acquisition and physical, maturational, and lifestyle variables during the pubertal transition in healthy girls. Forty-five girls, initially 10.5+/-0.6 years, participated. Body c
Autor:
Lynne M. Atley, Peter R. Ebeling, David K. B. Li, David R. Eyre, Yvette M. Vigna, Jerilynn C. Prior, John D. Wark, Brian C. Lentle
Publikováno v:
Journal of Bone and Mineral Research. 12:1851-1863
The purpose of this study was to contrast the effects of conventional estrogen treatment with medroxyprogesterone on cancellous and cortical bone change in the first year following premenopausal ovariectomy. This 1-year double-blind randomized therap
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:4176-4179
Publikováno v:
Fertility and Sterility. 63:1222-1226
Objective To assess whether temperature is increased by medroxyprogesterone (MPA) and thus whether basal temperature records could be used to determine ovulation during cyclic MPA therapy. Design A 2-month double-blind placebo-controlled crossover tr
Publikováno v:
The American Journal of Clinical Nutrition. 59:92-97
We assessed the relationship between dietary restraint and menstrual cycle characteristics in 27 ovulatory women, previous participants in a longitudinal study of spinal cancellous bone mineral density (BMD). Subjects completed the restraint scale of
Autor:
Yvette M. Vigna, Jerilynn C. Prior
Publikováno v:
Clinical Obstetrics and Gynecology. 34:180-190
Autor:
Jerilynn C, Prior, Jason D, Nielsen, Christine L, Hitchcock, Lucy A, Williams, Yvette M, Vigna, Charmaine B, Dean
Publikováno v:
Clinical science (London, England : 1979). 112(10)
Oestrogen therapy is the gold standard treatment for hot flushes/night sweats, but it and oestrogen/progestin are not suitable for all women. MPA (medroxyprogesterone acetate) reduces hot flushes, but its effectiveness compared with oestrogen is unkn